Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 9Recruiting 2Active not recruiting 2Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 55Gastrointestinal 34Thoracic 31CNS 27Breast 15Tumor-Agnostic 9Dermatologic 9Head & Neck 8Sarcoma 4NET 2Gynecologic 2Endocrine 2Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Ovarian Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 81Carboplatin 67pembrolizumab 62Bevacizumab 58Cisplatin 49Specimen Handling 29Drug Therapy 26Blood Specimen Collection 23olaparib 20Cyclophosphamide 18Taxes 17Magnetic Resonance Spectroscopy 16Letrozole 16Gemcitabine 16Biopsy 16liposomal doxorubicin 15niraparib 14Brachytherapy 14fludarabine 13Radiotherapy 13abemaciclib 12Injections 12Topotecan 11Nivolumab 11Doxorubicin 11lenvatinib 10Fulvestrant 10Fluorouracil 10Surveys and Questionnaires 9Standard of Care 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Radiosurgery × Gynecologic × Clear all
NCT05990192 2025-04-22

SOPRANO

Institute of Cancer Research, United Kingdom

Phase 2 Recruiting
42 enrolled
Gynecologic

Ovarian Neoplasms

NCT05444270 2023-11-24

SABR-ROC

Yonsei University

Phase NA Recruiting
270 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡